Navigation Links
Doctors See Return of Kaposi's Sarcoma in Handful of AIDS Patients

The skin cancer, which causes lesions, can be controlled with newer treatments

WEDNESDAY, Sept. 26 (HealthDay News) -- San Francisco doctors say they've seen a small number of longtime HIV patients with mild cases of Kaposi's sarcoma, a potentially dangerous condition that once plagued people with AIDS.

It's not clear why Kaposi's sarcoma is making a comeback, or whether it may pose a significant health threat to AIDS patients. Still, it's unusual that the condition is appearing in people who have largely controlled the AIDS virus in their bodies, said report lead author Dr. Toby Maurer, associate professor of dermatology at the University of California, San Francisco.

Kaposi's sarcoma, a type of skin cancer that causes disfiguring lesions, was largely limited to Mediterranean men before the AIDS epidemic. When the epidemic began in the United States, many gay men with AIDS developed the condition, apparently because their bodies already harbored the virus that causes it, Maurer said.

Kaposi's sarcoma stigmatized AIDS patients by causing lesions on their faces, and some people died. But a new generation of AIDS drugs released in the late 1990s helped patients strengthen their immune systems and kept Kaposi's sarcoma at bay, at least in the Western world.

The condition remains common in Africa, where it affects both men and women, Maurer said.

The condition hasn't disappeared entirely in the United States, however, and is still seen in AIDS patients who don't take antiretroviral drugs.

In a new report, published in a letter to the editor in the Sept. 27 issue of the New England Journal of Medicine, Maurer and his colleagues said they've seen an "unusual" cluster of nine cases of Kaposi's sarcoma in patients who have their HIV infection under control.

The patients, who were diagnosed with Kaposi's sarcoma between 2004 and 2006, had been HIV-positive for an average of 18 years and had taken antiretroviral AIDS drugs for an average of seven years. The average age of the patients was 51.

"They've been doing well for a long period of time, and they have Kaposi's sarcoma," Maurer said. "We're curious as to what this means. Is something going on with their immune systems after years of HIV and drug therapy? It's a reminder of how HIV presented 25 years ago, and it brings up a lot of questions and worries."

Fortunately, the new cases of Kaposi's sarcoma are not severe, although they do begin with lesions, Maurer said. Doctors can use a variety of treatments, including injections and a topical gel, to treat the condition.

Dr. David Aboulafia, attending hematologist and oncologist at Virginia Mason Clinic in Seattle, said AIDS patients should know that Kaposi's sarcoma remains very rare, especially when compared to the early days of the AIDS epidemic, when it struck about one-third of patients. And the treatments available today are effective and fairly easy for people to tolerate, he said.

More information

Learn more about Kaposi's sarcoma from the U.S. National Institutes of Health.

SOURCES: Toby Maurer, M.D., associate professor of dermatology, University of California, San Francisco, and chief of dermatology, San Francisco General Hospital; David Aboulafia, M.D., clinical professor of medicine, University of Washington, and attending hematologist/oncologist, Virginia Mason Clinic, Seattle; Sept. 27, 2007, New England Journal of Medicine

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Two doctors suspended for wrong brain surgery
5. Doctors at risk- the ugly side of the noble profession
6. Lure of the home turf brings back NRI doctors
7. Thakur warns doctors
8. Negligent doctors asked to cough up 3 lakhs for death of patient
9. Doctors advice early anemia tests
10. Emphasis to ban Drugs ads by Doctors
11. Doctors In UK Have Reservations About NHS Plan
Post Your Comments:
(Date:10/13/2017)... LEXINGTON, Ky. (PRWEB) , ... October 13, 2017 , ... ... MD, MPH to become its next President and Chief Executive Officer, succeeding Dr. James ... and CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end ...
(Date:10/13/2017)... CT (PRWEB) , ... October 13, 2017 , ... ... long-term care services, staged a mock evacuation of the facility as part of a ... Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology: